Monument Therapeutics Secures £1M Investment to Fund Its Schizophrenia Programme And Drive Next Stage of Growth

Written By Charlotte Kirby
Charlotte Kirby
Previous

Wazoku powers One Big Thing: empowering UK civil servants to drive change
Next

Qkine wins ‘Scale-up of the Year’ at the 2024 Cambridge Independent Business Awards